Due to the Covid-19 vaccination in the country, the second wave of coronavirus seems to be decreasing. Due to this, common side effects like mild fever, fatigue, weakness are being seen in people after vaccination. But many people are afraid of getting it done regarding the Covid vaccine. In such a situation, a new study by the Food and Drug Administration of America has come out.
Actually, the US Food and Drug Administration has prepared a fact sheet on the side effects of Moderna and Pfizer-BioNTech Covid-19 vaccines. It warns about the dangers of myocarditis and pericarditis caused by the vaccine. According to this report, there may be a risk of heart inflammation in two ways after vaccination, especially after taking the second dose of the vaccine.
Earlier this week, according to vaccine advisors from the US Centers for Disease Control and Prevention, the agency had received nearly 1,200 reports of heart inflammation after both 300 million doses of the vaccine were administered. The CDC has confirmed about 300 such cases, which involved people of both youth and adolescent age.
Pediatrician Dr. Matthew Oster told the consultants that such patients are also recovering quickly. According to the FDA, if a person experiences symptoms such as chest pain, shortness of breath, or rapid heartbeat after vaccination, they should immediately consult a doctor. They don’t need to panic.
The FDA said this update follows a comprehensive review and discussion of the information at the CDC’s Advisory Committee on Immunization Practice meeting on Wednesday. The decision to revise the data of the fact sheet presented in this meeting has been emphasized.
ACIP members agreed that vaccination may have a link between cases of heart inflammation in adolescents and adults. But with the treatment, all the cases improved and the patients recovered rapidly. The advisors said that the benefits of vaccination are high except in a few cases.
The FDA has said in a statement that the decision to revise the data of the fact sheet presented in this meeting has been emphasized. Both the FDA and CDC are assessing these adverse case reports and results.